Enamel caries
diseaseOn this page
Also known as dental caries limited to enameldental caries of enamelenamel dental caries
Summary
Enamel caries (MONDO:0002233) is a disease and 6 clinical trials. A subtype of dental caries — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 6
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | enamel caries |
| Mondo ID | MONDO:0002233 |
| DOID | DOID:217 |
| SNOMED CT | 80353004 |
| UMLS | C0266853 |
| MedGen | 540214 |
| Anatomy (UBERON) | UBERON:0001752 |
| Is cancer (heuristic) | no |
Also known as: dental caries limited to enamel · dental caries of enamel · enamel dental caries
Disease family
This is a subtype of dental caries. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › skeletal system disorder › tooth disorder › tooth hard tissue disease › dental caries › enamel caries
Related subtypes (4): dentin caries, odontoclasia, pit and fissure surface dental caries, smooth surface dental caries
Subtypes (1): root caries
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 6.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 6 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT03774498 | Not specified | UNKNOWN | Effect of Different Over-the-counter Toothpastes on Enamel Remineralization |
| NCT04155658 | Not specified | COMPLETED | Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation |
| NCT04685889 | Not specified | COMPLETED | Resin Infiltration Treatment for MIH |
| NCT04756557 | Not specified | COMPLETED | Caries-preventing Effect of a Hydroxyapatite-toothpaste in Adults |
| NCT05296213 | Not specified | COMPLETED | Medical Treatment of Early-Enamel Carious Lesion Using Different Remeneralizing Agents |
| NCT06425536 | Not specified | COMPLETED | Efficacy of Remineralizing Products Used in Molar Grooves: Evaluation With Diagnodent Pen and Diagnocam |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.